RxDoctor Payments Data

Richard Scharf, DO

Plastic Surgery within the Head & Neck · Roselle Park, NJNPI 1861439481

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (54.8%), consulting fees and education — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Optinose US, Inc. at 50.3% of the total. Reporting peaked in 2020 at $875 and has fallen 75.0% since, to $219 in 2025.

$1,894in general payments, 2019–2025

Across 43 payments — averaging $44.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Optinose US, Inc.$952
  • Aerin Medical Inc.$356
  • Regeneron Healthcare Solutions, Inc.$212
  • Merz North America, Inc.$133
  • Stryker$101
  • Novartis$22
  • plus $118 from 7 others

What the payments were for

  • Consulting fees$80042%
  • Food & beverage$1,03855%
  • Education$563%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few plastic surgery within the head & neck providers in New Jerseyto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$141,023
Medicare patients
456
Services billed
1,431

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluticasone Propionate226$4,924
Fluocinolone Acetonide Oil82$4,746
Azelastine-FluticasoneAzelastine/Fluticasone35$3,831
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth25$2,764
Triamcinolone Acetonide23$2,202
Famotidine127$2,105
Levocetirizine Dihydrochloride128$2,012
Ipratropium Bromide47$1,014
Montelukast Sodium56$937
Ofloxacin28$774
Mometasone Furoate36$609
Methylprednisolone66$478
Meclizine Hcl33$432
Cefdinir27$397
Omeprazole18$322

Paid to pharmacies, not to this prescriber.

Other plastic surgery within the head & neck in Roselle Park

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →